ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


  Click here to read this article as a CME activity


Ann Thorac Surg 2008;85:481-486. doi:10.1016/j.athoracsur.2007.10.014
© 2008 The Society of Thoracic Surgeons

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Marco Ranucci
Alfredo Pazzaglia
Giuseppe Bozzetti
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ranucci, M.
Right arrow Articles by Isgrò, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ranucci, M.
Right arrow Articles by Isgrò, G.
Related Collections
Right arrow Coronary disease
Right arrowRelated Article


Original Articles: Cardiovascular

Body Size, Gender, and Transfusions as Determinants of Outcome After Coronary Operations

Marco Ranucci, MD*, Alfredo Pazzaglia, MD, Chiara Bianchini, MD, Giuseppe Bozzetti, MD, Giuseppe Isgrò, MD

Department of Cardiothoracic–Vascular Anesthesia and Intensive Care, IRCCS Policlinico S. Donato, Milan, Italy

Accepted for publication October 2, 2007.

* Address correspondence to Dr Ranucci, Department of Anesthesia and Intensive Care, IRCCS Policlinico S. Donato, Via Morandi 30, San Donato–Milanese, Milan, 20097, Italy (Email: cardioanestesia{at}virgilio.it).


Cardiothoracic anesthesiology: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS member or an individual non-member subscription to the journal.

 

    Abstract
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Comment
 References
 
Background: Small body size, female gender, and transfusions are traditionally considered morbidity and mortality risk factors in coronary surgery. Because these clinical conditions are interrelated, we designed a study to investigate their respective roles in determining adverse outcomes after coronary operations.

Methods: A retrospective study on 4,546 consecutive patients who underwent coronary surgery was performed. The outcome (hospital mortality and length of stay in the intensive care unit) was evaluated according to body surface area, gender, and the presence of allogeneic blood transfusions.

Results: Female gender is not a risk factor for hospital mortality or prolonged intensive care unit stay. Small body surface area in men and large body surface area in women are associated with a prolonged intensive care unit stay. Transfusions are independent risk factors for both mortality and prolonged intensive care unit stay. Fresh-frozen plasma and platelet transfusion carry a higher mortality risk (odds ratio, 12) than transfusions of packed red blood cells (odds ratio, 5).

Conclusions: Female gender and small body surface area are associated with severe intraoperative hemodilution, and this may trigger blood transfusions, which are true determinants of adverse outcomes. A large body surface area in women is frequently associated with obesity (68%) and may prolong the intensive care unit stay, whereas it is not a risk factor in men. Conversely, a small body surface area is accompanied by a prolonged intensive care unit stay in men but not in women.

Female gender and small body size (body surface area, body mass index, or body weight) are considered independent risk factors for adverse outcomes in coronary surgery [1–12]. Several investigators have addressed the role of female gender [1, 3, 6, 9, 10], small body size [5, 7, 8, 11], or both [2] on outcomes in coronary surgery.

Female gender was found to be an independent predictor for early mortality [1, 2, 4, 6, 10]; one article reported increased early mortality but only for low- or medium-risk patients [3]. A higher morbidity rate was reported in women; this includes composite severe morbidity [1, 4], low cardiac output syndrome [2], perioperative myocardial infarction, need for inotropic agents, and prolonged mechanical ventilation time [9]. Interestingly, all studies addressing late mortality found no gender-related differences or even better results in female patients [1, 4, 10, 12].

Small body size was independently associated with early mortality [5, 7] as well as different kinds of morbidity, including perioperative myocardial infarction, stroke, length of hospital stay [5]; acute renal failure and prolonged hospital stay [7]; reoperation and lung dysfunction [11]; and other composite indices [8]. One study failed to detect body size–related increases in morbidity [2].

Female gender is generally associated with a smaller body size, but the respective role of the two factors is still unclear, as demonstrated by the fact that the most commonly used morbidity and mortality risk scores may include either gender [13–18], body size [18], or both [13, 15, 16, 18]. Moreover, some studies demonstrated that female gender and a small body size are associated with an increased risk of receiving allogeneic blood product transfusions [5, 7, 11, 19], and one recent study suggested that transfusions, rather than female gender, were responsible for mortality and morbidity (namely infections) after coronary operations [19].

The interaction among these three potential risk factors (female gender, small body size, and transfusions) was not completely addressed with adequate statistical tests in all the previous studies, therefore maintaining open the debate about their respective role in determining morbidity and mortality after coronary operations. We hypothesize that female gender and small body size may simply trigger transfusions, which could be the real determinant of adverse outcomes.

The aim of the present study is to provide a comprehensive analysis of the respective role of female gender, small body size, and transfusions as potential independent predictors of mortality or prolonged intensive care unit (ICU) stay after coronary operations.


    Patients and Methods
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Comment
 References
 
The present study is based on a retrospective analysis of the cardiac surgical activity at our institution for the past 6 years.

Patients
A series of 4,546 consecutive patients, who underwent isolated coronary surgery with cardiopulmonary bypass (CPB) at our institution in the period December 1, 2001, through March 31, 2007, was retrospectively analyzed using a local computerized database. Sixty-three patients who underwent off-pump coronary surgery were excluded from study. All patients provided written consent to the scientific treatment of their data, and the local ethical committee waived the need for approval.

Intraoperative Anesthetic Management, Monitoring, and Cardiopulmonary Bypass
Anesthesia was induced and maintained with intravenous agents. All patients received tranexamic acid intravenously (15 mg/kg before CPB and 15 mg/kg after protamine administration). Aprotinin was never used (it is not commercially available in Italy). Cardiopulmonary bypass was conducted using either closed or open circuits, standard or phosphorylcholine-coated hollow-fiber oxygenators, and roller or centrifugal pumps according to availability. Regardless of the circuit used, the priming volume was always minimized to 800 to 1,000 mL.

Data Collection and Definitions
The following variables were collected for a preoperative profile: demographics (including body surface area [BSA] and body mass index), left ventricular ejection fraction, serum creatinine value (mg/dL), unstable angina, recent myocardial infarction, hematocrit (%, HCT), extracardiac arteriopathy, diabetes on medication, chronic obstructive pulmonary disease, neurologic dysfunction, previous cardiac surgery, chronic congestive heart failure, pulmonary hypertension, active endocarditis, and critical preoperative state.

The following variables were collected for perioperative data: urgent operation, emergency operation, CPB duration (minutes), number of distal anastomoses, internal mammary artery use, lowest HCT on CPB, lowest temperature on CPB, and need for allogeneic blood products during the operation or the ICU stay.

The following variables were collected as outcome variables: peak serum creatinine value (mg/dL), acute renal failure (peak serum creatinine value twice the baseline value), low cardiac output (need for inotropic agents for more than 24 hours), need for intraaortic balloon pump, myocardial infarction (new Q waves plus enzymatic criteria), severe lung dysfunction (more than 48 hours of mechanical ventilation as a result of poor arterial blood gas analyses), stroke, sepsis, severe morbidity (one of the following: low cardiac output, myocardial infarction, intraaortic balloon pump, stroke, acute renal failure, or sepsis), ICU stay (days), and hospital mortality (within 30 days from the operation).

Every risk condition was established according to EuroSCORE definitions [17].

Statistical Analysis
The outcome variables considered were hospital mortality and morbidity, defined as the length of ICU stay in surviving patients.

The first statistical step was to separately assess the association between gender, BSA, transfusions, and the outcome variables. The second step was identifying the preoperative and intraoperative variables associated with outcome variables using univariate analysis (relative risk with 95% confidence interval or unpaired Student’s t test when appropriate). Subsequently, outcome variables that were significantly associated (p < 0.05) with preoperative and intraoperative variables were examined with multivariable analysis (stepwise forward multivariate linear regression for continuous variables and stepwise forward multivariate logistic regression for binary variables). To avoid overfitting the model, the number of independent variables entered into each model was limited to 1 for every 10 events. When appropriate, a Bonferroni correction of the multivariable analyses was applied. Tolerance and inflation statistics were applied to assess intercorrelation between independent variables.

Other statistical procedures included the locally weighted scatterplot smoothing (LOWESS) [20] for investigating nonlinear association between continuous variables.

The data in the tables are reported as mean and standard deviation of the mean or as a count and percentage. A probability value of less than 0.05 was considered significant for all the statistical tests. Statistical calculations were performed using a computerized statistical program (SPSS 11.0, Chicago, IL).


    Results
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Comment
 References
 
Hospital Mortality
Female gender demonstrated a significant (p = 0.048) association with hospital mortality at the univariate analysis (Table 1). No association was found with the BSA. Overall transfusion, packed red blood cells (PRCs), fresh-frozen plasma (FFP), and platelet transfusions were all significantly associated with hospital mortality. Female gender and BSA were explored for their association with transfusions: female gender is significantly associated with the overall transfusion risk (relative risk, 2.4; 95% confidence interval, 2.1 to 2.8; p = 0.001) and with PRCs transfusion risk (relative risk, 2.4; 95% confidence interval, 2.1 to 2.7; p = 0.001) but not with FFP and platelet transfusion risk. Body surface area is associated with overall and PRCs transfusion risk (p = 0.001) and with FFP transfusion risk (p = 0.004) but not with platelet transfusion risk. In a multivariable logistic regression model, after correction for age and lowest HCT on CPB, both female gender and BSA lost significance in predicting transfusional needs.


View this table:
[in this window]
[in a new window]

 
Table 1 In-Hospital Mortality According to Gender, Body Surface Area, and Transfusions
 
The other variables associated with hospital mortality were age, left ventricular ejection fraction, preoperative serum creatinine value, chronic obstructive pulmonary disease, previous cerebrovascular accident, diabetes on medication, urgent operation, CPB duration, and lowest HCT on CPB. Multivariable models were calculated by separately correcting gender and transfusions for the other explanatory variables. In each model, the study variables were separately considered as a result of their intercorrelation. After correction for these confounding factors, female gender was no longer associated with mortality, whereas transfusions remained an independent risk factor for mortality, with odds ratios of 5.8 for PRCs transfusion, 12.6 for FFP transfusion, and 13.6 for platelet transfusion.

Hemodilution during CPB was more pronounced in women than in men (lowest HCT on CPB, 23.7% ± 3.3% versus 27.6% ± 3.5%; p = 0.001), and BSA is significantly associated with hemodilution during CPB. These associations, if considered within a multivariable model of linear regression, remain significant (p = 0.001; Fig 1). The degree of hemodilution during CPB is associated (p = 0.001) with the risk of transfusing PRCs, but not FFP and platelets, after correction for the other confounding factors in a multivariable logistic regression model (Fig 2).


Figure 1
View larger version (9K):
[in this window]
[in a new window]

 
Fig 1. Association of body surface area with the degree of hemodilution during cardiopulmonary bypass is shown. (CPB = cardiopulmonary bypass; HCT = hematocrit.)

 

Figure 2
View larger version (7K):
[in this window]
[in a new window]

 
Fig 2. Predictive risk function for packed red blood cell transfusions is shown according to the lowest hematocrit on cardiopulmonary bypass.

 
Intensive Care Unit Stay
Only surviving patients were entered into this analysis. At the univariate step, no association was found between female gender and the length of ICU stay or prolonged ICU stay (Table 2). The BSA was significantly associated with a prolonged ICU stay (a lower BSA leading to a higher risk). Overall transfusions were significantly associated with both the length of ICU stay and the risk of a prolonged ICU stay. When corrected for the other confounding variables at the multivariable analysis, only transfusions remained independently associated with the outcome variables.


View this table:
[in this window]
[in a new window]

 
Table 2 Intensive Care Unit Stay According to Gender, Body Surface Area, and Transfusions
 
The relationship between BSA and the length of ICU stay was visually inspected on a graphic plot, and appeared to be nonlinear, with the longest values of ICU stay at the small and large values of BSA. Therefore, BSA could not be treated as a continuous variable in the analysis of its association with the length of ICU stay. Using the LOWESS technique, the relationship was graphically analyzed separately for men and women (Fig 3).


Figure 3
View larger version (9K):
[in this window]
[in a new window]

 
Fig 3. Intensive care unit stay is shown according to the body surface area. Locally weighted scatterplot smoothing adjustment is shown for women and men. Obesity rates were assessed for body surface area values higher than 1.9 m2.

 
The relationship is U-shaped, and this shape results from a longer ICU stay for a small BSA in men, and for a large BSA in women. The population with a BSA greater than 1.9 was explored for the patient’s obesity rate (defined as a body mass index of 30 or greater). In this subpopulation, the obesity rate is significantly (p = 0.001) higher in women than in men (68% versus 31%).

The same graphic relationship was created for men and women being transfused or not transfused (Fig 4). Data from patients who were not transfused confirmed the previous behavior; conversely, patients being transfused have the longer ICU stay in correspondence with larger BSA values, regardless of gender.


Figure 4
View larger version (9K):
[in this window]
[in a new window]

 
Fig 4. Intensive care unit stay according to the body surface area is shown. Locally weighted scatterplot smoothing adjustment is shown for females and males being transfused or not.

 

    Comment
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Comment
 References
 
The main results of our study are as follows:
1 Female gender is not an independent risk factor for mortality if considered within a multivariable model inclusive of other explanatory variables.
2 Female gender and a small BSA are associated with a greater hemodilution during CPB and with a higher transfusion risk.
3 The ICU length of stay may be dependent on the BSA and the gender. Small-sized men and large-sized women have the longest time of ICU stay.
4 Transfusions are independently associated with hospital mortality. The higher risk is carried by FFP and platelet transfusions.
5 Transfusions may prolong the length of stay in the ICU. The longest time of ICU stay is found in large-sized patients (regardless of gender) being transfused.

On the basis of the above information, we cannot confirm that female gender is per se a risk factor in coronary operations, as hypothesized by other authors [1–11]. We believe that this results from the inclusion of the lowest HCT on CPB within the possible confounding factors. This factor has been associated with morbidity and mortality in many previous studies [21–24].

Both female gender and a small BSA are associated with a higher degree of hemodilution during CPB; this may directly deteriorate the outcome, and even lead to transfusions as a result of a low hemoglobin level during and after the operation. Transfusions are a well-recognized factor responsible for adverse outcomes [25–27], and therefore this chain of events may justify the link between female gender or small BSA and adverse outcomes found by other authors. The deleterious effects of transfusions seem more pronounced for FFP and platelets. It is presently still debated whether platelet transfusions are associated with increased mortality and morbidity after cardiac surgery [28]. In our setting, FFP and platelet transfusions are generally used to treat postoperative bleeding, and surgical revision attributable to bleeding is always accompanied by FFP and often by platelet transfusion. Therefore, it is not surprising that these blood products, being a marker of postoperative bleeding, carry a higher mortality risk than simple PRC transfusions.

The possible role of BSA in prolonging postoperative ICU stay should be carefully addressed. Body surface area is a difficult variable from the statistical point of view: it appears that both small and large values may be associated with a prolonged ICU stay. Moreover, the behavior is different from men to women: the first have the worst outcome if small-sized, the second if large-sized. Analyzing the obesity rate on the basis of the body mass index, we could demonstrate that there is a highly different distribution of fat and muscle between large-sized men and women. Large-sized women are much more likely to be obese than are men, and this may justify their longer ICU stay: the greater amount of fat and the consequent relatively lower circulating red blood cell mass predispose them to hemodilution, transfusions, respiratory problems, and superficial and deep mediastinal infections. On the other side, small-sized men may suffer from a higher degree of hemodilution during CPB with the already mentioned relative complications.

A further matter of debate is introduced by the changes induced by transfusions. Patients who do not receive transfusions and women who are transfused correspond to the above-described gender-dependent behavior. Conversely, men being transfused have the longest ICU stay when large-sized. Our interpretation is that in this case the transfusions are probably triggered not by a low hemoglobin level (which is rare in this subset of patients), but by the presence of adverse events suggesting a higher target value of hemoglobin (eg, low output state, acute renal failure, stroke) or by a serious postoperative bleeding with or without the need for a surgical revision.

It is always difficult to address the impact of allogeneic blood products on the postoperative outcome of cardiac surgery patients. In the presence of severe complications, and especially when one or more organs are at risk for ischemia, the hemoglobin-based transfusion trigger is increased [27]. At our institution, the usual hemoglobin value for considering PRC transfusion is 8 g/dL, but it can be increased to 9 or even 10 g/dL in the presence of severe postoperative complications (low cardiac output, myocardial infarction, stroke, acute renal failure, sepsis). Therefore, the link between transfusions and adverse outcomes can be coincidental rather than causative.

The link between gender, body size, and transfusions, as well as their respective roles in changing the outcomes, has not been widely addressed in previous studies. However, Guru and coworkers [10] confirmed that female gender, if adjusted for BSA, is not an independent risk factor for morbidity after coronary operations. Koch and coworkers [9] approached the problem with a propensity-score matching, and once the gender-related groups were adequately matched, no differences in outcome were observed. Potapov and coworkers [8] again confirmed that a small body size is a risk factor independent of gender. Finally, two interesting articles discussed issues with transfusions: Schwann and coworkers [5] found that patients with a low body mass index were more hemodiluted during the operation and received more transfusions during and after the operation. They hypothesize that this could be one of the mechanisms underlying the higher morbidity rate, namely at the level of lung function and infections. Recently, Rogers and coworkers [19] confirmed that women were more prone to receive allogeneic blood products and this could explain their higher rate of infections.

The main limitation of our study is the retrospective nature of the data collection; however, it is difficult to hypothesize a prospective trial based on gender, BSA, and transfusions as independent variables, and the majority of the studies in this field are retrospective as well. Another limitation is that we are missing data about the quality of the coronary vessels in women and small BSA patients. This factor has been considered a reason for the higher morbidity and mortality rate in some studies [2, 3], together with other possible operation-related factors like the number of anastomoses and rate of internal mammary artery use (which were not significantly different between groups in our study).

The main strength of this study is that we applied a multivariable analysis including the intraoperative degree of hemodilution (which was missing in all the previous studies) in the model, and that we introduced the concept that BSA may behave differently, as a risk factor, in women versus men. This approach enabled us to conclude that a small BSA or female gender may be considered a morbidity or mortality risk factor for coronary operations basically because of the greater hemodilution during the operation and the associated higher transfusion rate. Finally, this study generates the hypothesis that applying adequate measures for containing the degree of hemodilution in women and small BSA patients could result in improvements in their postoperative outcome. This hypothesis requires adequate prospective trial testing for confirmation.


    References
 Top
 Abstract
 Introduction
 Patients and Methods
 Results
 Comment
 References
 

  1. Christakis GT, Weisel RD, Buth KJ, et al. Is body size the cause for poor outcomes of coronary artery bypass operations in women? J Thorac Cardiovasc Surg 1995;110:1344-1358.[Abstract/Free Full Text]
  2. Brandrup-Wognsen G, Berggren H, Hartford M, Hjalmarson Å, Karlsson T, Herltz J. Female sex is associated with increased mortality and morbidity early, but not late, after coronary artery bypass grafting Eur Heart J 1996;17:1426-1431.[Abstract/Free Full Text]
  3. Edwards FH, Carey JS, Grover FL, Bero JW, Hartz RS. Impact of gender on coronary bypass operative mortality Ann Thorac Surg 1998;66:125-131.[Abstract/Free Full Text]
  4. Abramov D, Tamariz MG, Sever JY, et al. The influence of gender on the outcome of coronary artery bypass surgery Ann Thorac Surg 2000;70:800-806.[Abstract/Free Full Text]
  5. Schwann TA, Habib RH, Zacharias A, et al. Effects of body size on operative, intermediate, and long-term outcomes after coronary artery bypass operation Ann Thorac Surg 2001;71:521-531.[Abstract/Free Full Text]
  6. Zitser-Gurevich Y, Simchen E, Galai N, Mandel M, The ISCAB Consortium Effect of perioperative complications on excess mortality among women after coronary artery bypass: the Israeli Coronary Artery Bypass Graft study (ISCAB) J Thorac Cardiovasc Surg 2002;123:517-524.[Abstract/Free Full Text]
  7. Reeves BC, Ascione R, Chamberlain MH, Angelini GD. Effect of body mass index on early outcomes in patients undergoing coronary artery bypass surgery J Am Coll Cardiol 2003;42:668-676.[Abstract/Free Full Text]
  8. Potapov EV, Loebeb M, Ankerc S, et al. Impact of body mass index on outcome in patients after coronary artery bypass grafting with and without valve surgery Eur Heart J 2003;24:1933-1941.[Abstract/Free Full Text]
  9. Koch CG, Khandwala F, Nussmeier N, Blackstone EH. Gender and outcomes after coronary artery bypass grafting: a propensity-matched comparison J Thorac Cardiovasc Surg 2003;126:2032-2043.[Abstract/Free Full Text]
  10. Guru V, Fremes SE, Tu JV. Time-related mortality for women after coronary artery bypass graft surgery: a population-based study J Thorac Cardiovasc Surg 2004;127:1158-1165.[Abstract/Free Full Text]
  11. Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A. Effects of obesity and small body size on operative and long-term outcomes of coronary artery bypass surgery: a propensity-matched analysis Ann Thorac Surg 2005;79:1976-1986.[Abstract/Free Full Text]
  12. Toumpoulis IK, Anagnostopoulos CE, Balaram SK, et al. Assessment of independent predictors for long-term mortality between women and men after coronary artery bypass grafting: are women different from men? J Thorac Cardiovasc Surg 2006;131:343-351.[Abstract/Free Full Text]
  13. Parsonnet V, Dean D, Bernstein AD. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease Circulation 1989;79:I-3-I-12.[Medline]
  14. Tu JV, Jaglal SB, Naylor CD. Multicenter validation of risk index for mortality, intensive care unit stay, and overall hospital length of stay after cardiac surgerySteering Committee of the Provincial Adult Cardiac Care Network of Ontario. Circulation 1995;91:677-684.[Abstract/Free Full Text]
  15. Bernstein AD, Parsonnet V. Bedside estimation of risk as an aid for decision making in cardiac surgery Ann Thorac Surg 2000;69:823-828.[Abstract/Free Full Text]
  16. O’Connor GY, Plume SK, Olmstead EM, et al. Multivariate prediction of in-hospital mortality associated with coronary artery bypass surgeryThe Northern New England Cardiovascular Disease Study Group. Circulation 1992;85:2110-2118.[Abstract/Free Full Text]
  17. Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19,030 patients Eur J Cardiothorac Surg 1999;15:816-822.[Abstract/Free Full Text]
  18. Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patientsA clinical severity score. JAMA 1992;267:2344-2348.[Abstract]
  19. Rogers MAM, Blumberg N, Saint SK, Kim C, Nallamothu BK, Langa KM. Allogenic blood transfusions explain increased mortality in women after coronary artery bypass graft surgery Am Heart J 2006;152:1028-1034.[Medline]
  20. Cleveland WS. Robust locally weighted regression and smoothing scatterplots J Am Statist Assoc 1979;74:829-836.
  21. Habib RH, Zacharias A, Schwann TA, et al. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed? J Thorac Cardiovasc Surg 2003;125:1438-1450.[Abstract/Free Full Text]
  22. Swaminathan M, Phillips-Bute BG, Conlon PJ, et al. The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery Ann Thorac Surg 2003;76:784-792.[Abstract/Free Full Text]
  23. Karkouti K, Beattie WS, Wijeysundera DN, et al. Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery J Thorac Cardiovasc Surg 2005;129:391-400.[Abstract/Free Full Text]
  24. Ranucci M, Romitti F, Isgrò G, et al. Oxygen delivery during cardiopulmonary bypass and acute renal failure following coronary operations Ann Thorac Surg 2005;80:2213-2220.[Abstract/Free Full Text]
  25. Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ. Effect of blood transfusions on long-term survival after cardiac operation Ann Thorac Surg 2002;74:1880-1886.
  26. Leal-Noval SR, Rincón-Ferrari, MD, García-Curiel A, et al. Transfusion of blood components and postoperative infection in patients undergoing cardiac surgery Chest 2001;119:1461-1468.[Medline]
  27. Ferraris VA, Ferraris SP, Saha SP, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists clinical practice guideline Ann Thorac Surg 2007;83:27-86.
  28. Karkouti K, Wijeysundera DN, Yau TM, et al. Platelet transfusions are not associated with increased morbidity or mortality in cardiac surgery Can J Anaesth 2006;53:279-287.[Abstract/Free Full Text]

Related Article

Invited Commentary
Colleen Gorman Koch
Ann. Thorac. Surg. 2008 85: 487. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
C. G. Koch
Invited Commentary
Ann. Thorac. Surg., February 1, 2008; 85(2): 487 - 487.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Marco Ranucci
Alfredo Pazzaglia
Giuseppe Bozzetti
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ranucci, M.
Right arrow Articles by Isgrò, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ranucci, M.
Right arrow Articles by Isgrò, G.
Related Collections
Right arrow Coronary disease
Right arrowRelated Article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS